Literature DB >> 16673263

The structure of thrombin: a janus-headed proteinase.

Wolfram Bode1.   

Abstract

Through a series of successive, cascade-like proteinase activation and amplification steps, any vascular injury triggers a rapid burst of alpha-thrombin, a trypsin-like serine proteinase. Thrombin, the main executioner of the coagulation cascade, has procoagulant as well as anticoagulant and antifibrinolytic properties. It exhibits quite diverse physiological functions, but also gives rise to several thrombotic disorders, such as thromboembolism, myocardial infarction, and stroke, thus making it an attractive target for antithrombotic agents. Thrombin interacts specifically with several protein substrates, receptors, cofactors, inhibitors, carbohydrates, and modulators. It cleaves fibrinogen, factors XI (FXI) and FXIII, cofactors V and VIII, and the thrombin receptors; uses thrombomodulin to activate protein C and thrombin-activatable-fibrinolysis inhibitor; is inhibited by heparin cofactor II and antithrombin III with the help of acidic carbohydrates; and its activity/specificity is modulated by sodium ions. A large number of crystal structures of alpha-thrombin in complexes with synthetic polypeptides and protein inhibitors, substrate fragments, cofactors, and carbohydrates have displayed extended recognition sites on the thrombin surface, reflecting the versatility and multifunctional specificity of this remarkable proteinase. These structures essentially show that the thrombin surface can be subdivided into several functional regions, which recognize different chemical moieties. By using different combinations of these surface elements, thrombin can interact with a variety of molecules with high specificity, accounting for its multifunctional properties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673263     DOI: 10.1055/s-2006-939551

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  30 in total

Review 1.  Hageman factor, platelets and polyphosphates: early history and recent connection.

Authors:  J Caen; Q Wu
Journal:  J Thromb Haemost       Date:  2010-04-30       Impact factor: 5.824

2.  Thrombin-dependent MMP-2 activity is regulated by heparan sulfate.

Authors:  Bon-Hun Koo; Jung Ho Han; Young Il Yeom; Doo-Sik Kim
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

3.  Interaction of thrombin with sucrose octasulfate.

Authors:  Bijoy J Desai; Rio S Boothello; Akul Y Mehta; J Neel Scarsdale; H Tonie Wright; Umesh R Desai
Journal:  Biochemistry       Date:  2011-07-18       Impact factor: 3.162

4.  Meizothrombin is an unexpectedly zymogen-like variant of thrombin.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

5.  Tri-arginine exosite patch of caspase-6 recruits substrates for hydrolysis.

Authors:  Derek J MacPherson; Caitlyn L Mills; Mary Jo Ondrechen; Jeanne A Hardy
Journal:  J Biol Chem       Date:  2018-11-12       Impact factor: 5.157

6.  Aggregation of thrombin-derived C-terminal fragments as a previously undisclosed host defense mechanism.

Authors:  Jitka Petrlova; Finja C Hansen; Mariena J A van der Plas; Roland G Huber; Matthias Mörgelin; Martin Malmsten; Peter J Bond; Artur Schmidtchen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-04       Impact factor: 11.205

7.  Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.

Authors:  Madhavi A Jadhav; R Cory Lucas; Whitney N Goldsberry; Muriel C Maurer
Journal:  Biochim Biophys Acta       Date:  2011-07-21

8.  The role of thrombin exosites I and II in the activation of human coagulation factor V.

Authors:  Kenneth Segers; Björn Dahlbäck; Paul E Bock; Guido Tans; Jan Rosing; Gerry A F Nicolaes
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

9.  Proteolysis of human thrombin generates novel host defense peptides.

Authors:  Praveen Papareddy; Victoria Rydengård; Mukesh Pasupuleti; Björn Walse; Matthias Mörgelin; Anna Chalupka; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

10.  Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition.

Authors:  Preetpal Singh Sidhu; May H Abdel Aziz; Aurijit Sarkar; Akul Y Mehta; Qibing Zhou; Umesh R Desai
Journal:  J Med Chem       Date:  2013-06-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.